Sjukhuset i Lidköping är ett akutsjukhus beläget i centrala Lidköping invid ån Lidan. Sjukhuset har runt 700 anställda samt drygt 140 sängplatser. Inom dess upptagningsområde bor cirka 85 000 personer. Sjukhuset grundades 1934. Sjukhuset är ett av fyra sjukhus inom Skaraborgs sjukhus.

During the past decade, Lidköping Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lidköping Hospital" #1 sponsor was "Karolinska Institutet" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Nordic Myeloma Study Group" with 1 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 1 trials sponsored and "Uppsala University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lidköping Hospital" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "Centrallasarettet Västerås" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "European Myeloma Network" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Lidköping Hospital" are "Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Cardiovascular Diseases" (1 trials), "GastroIntestinal Bleeding" (1 trials) and "Helicobacter Pylori Infection" (1 trials). Many other conditions were trialed in "Lidköping Hospital" in a lesser frequency.

Most popular intervention types in "Lidköping Hospital" are "Drug" (4 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Bortezomib" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials) and "Icodextrin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lidköping Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lidköping Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lidköping Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lidköping Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".